Autologous vaccines harness the body’s own immune system to fight cancer. Derived from a patient’s cancer cells, these vaccines are cultivated in the lab and combined with an immuno-stimulant to trigger an immune response. When the vaccine is administered back into the patient, it equips the immune system to recognize and eliminate cancer cells while preserving healthy tissue.
ATA therapy
Whole peripheral blood sample
25ml
Cancer with solid tumors or non-compartmentalized cancers
21 days
Tumor cells from each patient have unique gene mutations that encode for tumor-associated antigens (TAAs), which are crucial for anti-tumor immune responses. Vaccine Preparation from Fragmented Tumor Cell Antigens, utilizes autologous cancer cells, specifically circulating tumor cells (CTCs), to stimulate the immune system and target cancer cells effectively.
The process begins with isolating circulating tumor cells (CTCs) from the patient’s blood, which are then screened and sequenced to identify tumor cell antigens. Specific epitopes are selected, and peptides are designed accordingly. Necrotic whole tumor cell lysate is commonly used to prepare tumor cells for the vaccine, which is then administered to the patient.
ATA therapy is applied at various stages to stop cancer progression. It is beneficial for patients with active cancer not undergoing concurrent chemotherapy or radiation therapy. Additionally, it is suitable for patients at risk of recurrence seeking to reduce its likelihood. This therapy not only halts tumor growth and prevents recurrence but also synergizes with other treatments for enhanced efficacy.
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.
Requires 20-30 ml of blood sample
Patients need to avoid chemotherapy, targeted therapies, radiation, IVs, and Ozone therapy 7 days before ATA VACCINE administration.
Patients should not be on immune suppression therapy up to 45 days prior to the application of ATA VACCINE.
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.
RGCC tests like Metastat accurately detect the development of secondary tumors.
Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells. Once testing is complete, your sample is stored for up to six months in case further analysis is needed.
Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.
Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.
Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.
Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.
Indeed, tests are designed to reveal whether cancer cells are resistant or sensitivity to specific drugs and treatments.
Exhausted from trying various cancer treatments? Consider ATA therapy. It activates and stimulates the immune system to effectively targets cancer cells. Whether it’s active cancer or recurrence, ATA therapy offers promising results. Embrace a treatment that works best for your cancer!
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
Copyright 2024 © All Right Reserved.
Designed by Bee High Media
Dr Meghan WattsOncologist